WIRE — Profits at state-owned Sociedade Moçambicana de Medicamentos (SMM) fell 98.5% in 2025 to 10.1 million meticais (€137,000), according to the company's financial statements, which Lusa accessed on Tuesday. According to the report, SMM (Mozambique Medicines Company) recorded a positive net result in 2025, although well below the profit of 674.7 million meticais (€9.1 million) recorded Source
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.